NO991198D0 - FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel - Google Patents

FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Info

Publication number
NO991198D0
NO991198D0 NO991198A NO991198A NO991198D0 NO 991198 D0 NO991198 D0 NO 991198D0 NO 991198 A NO991198 A NO 991198A NO 991198 A NO991198 A NO 991198A NO 991198 D0 NO991198 D0 NO 991198D0
Authority
NO
Norway
Prior art keywords
plasma
protein
medicament
citrate
preparation
Prior art date
Application number
NO991198A
Other languages
English (en)
Other versions
NO991198L (no
Inventor
Wolfgang Teschner
Yendra Linnau
Sonja Svatos
Herwig Igel
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991198(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO991198D0 publication Critical patent/NO991198D0/no
Publication of NO991198L publication Critical patent/NO991198L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991198A 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel NO991198L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
PCT/AT1997/000197 WO1998012225A2 (de) 1996-09-16 1997-09-10 Verfarhen zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (2)

Publication Number Publication Date
NO991198D0 true NO991198D0 (no) 1999-03-11
NO991198L NO991198L (no) 1999-05-14

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991198A NO991198L (no) 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Country Status (24)

Country Link
US (3) US20020034809A1 (no)
EP (1) EP0927195B1 (no)
JP (1) JP2001500867A (no)
KR (1) KR20000036002A (no)
CN (1) CN1230967A (no)
AR (1) AR009582A1 (no)
AT (2) AT403989B (no)
AU (1) AU732519B2 (no)
BR (1) BR9712044A (no)
CA (1) CA2265936C (no)
CZ (1) CZ91199A3 (no)
DE (1) DE59710700D1 (no)
DK (1) DK0927195T3 (no)
ES (1) ES2206701T3 (no)
HU (1) HUP0002265A3 (no)
ID (1) ID21224A (no)
IL (1) IL128770A0 (no)
IN (1) IN187314B (no)
MX (1) MXPA99002144A (no)
NO (1) NO991198L (no)
PL (1) PL332159A1 (no)
PT (1) PT927195E (no)
SK (1) SK32899A3 (no)
WO (1) WO1998012225A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
HUP0402315A3 (en) 2001-12-21 2009-03-30 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
AU2004241698A1 (en) * 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
CA2534028A1 (en) 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
EP3835420A1 (en) 2011-12-05 2021-06-16 Factor Bioscience Inc. Methods and products for transfecting cells
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
CN111344410B (zh) 2017-08-17 2023-09-15 济世易为生物有限公司 从宿主细胞半乳糖凝集素和其他污染物中纯化糖基化蛋白的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
KR20000036002A (ko) 2000-06-26
ATA163396A (de) 1997-12-15
CZ91199A3 (cs) 1999-06-16
HUP0002265A3 (en) 2003-01-28
US8709492B2 (en) 2014-04-29
AU732519B2 (en) 2001-04-26
ID21224A (id) 1999-05-06
MXPA99002144A (es) 2005-04-28
ES2206701T3 (es) 2004-05-16
EP0927195B1 (de) 2003-09-03
PT927195E (pt) 2004-01-30
CA2265936C (en) 2008-04-22
CN1230967A (zh) 1999-10-06
US20050249815A1 (en) 2005-11-10
DK0927195T3 (da) 2003-11-24
JP2001500867A (ja) 2001-01-23
IN187314B (no) 2002-03-23
PL332159A1 (en) 1999-08-30
EP0927195A2 (de) 1999-07-07
ATE248857T1 (de) 2003-09-15
BR9712044A (pt) 1999-08-24
US20140234292A1 (en) 2014-08-21
AR009582A1 (es) 2000-04-26
AT403989B (de) 1998-07-27
US20020034809A1 (en) 2002-03-21
CA2265936A1 (en) 1998-03-26
HUP0002265A2 (hu) 2000-11-28
WO1998012225A3 (de) 1998-04-23
DE59710700D1 (de) 2003-10-09
AU4289997A (en) 1998-04-14
IL128770A0 (en) 2000-01-31
WO1998012225A2 (de) 1998-03-26
NO991198L (no) 1999-05-14
SK32899A3 (en) 1999-08-06

Similar Documents

Publication Publication Date Title
NO991198D0 (no) FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel
DE69628148D1 (de) Verfahren zur herstellung eines proteins
AU2001232735A1 (en) Process for solubilizing glucagon-like peptide 1 compounds
ATE315105T1 (de) Nucleinsauremoleküle mit spezifischer erkennung von nativem prpsc, herstellung und verwendung
DE68927669D1 (de) Verfahren zur herstellung von in lösungsmitteln verdünnbaren mikroträgern
Sachdev et al. Pyridyl esters of peptides as synthetic substrates of pepsin
PL328712A1 (en) Anionic salts of non-narcotic analgetic agents of carboxylic acid type combined with morphine and diamorphine, method of obtaining them, their application and pharmaceutic agents containing such salts
DE59404646D1 (de) Verfahren zur reinigung von 1- n(2 -((s)-ethoxycarbonyl)-3-phenylpropyl)-n6 -trifluoraceytl]-l-lysyl-l-prolin (lisinopril(tfa)ethylester)
ATE312863T1 (de) Verfahren zur reinigung von aldehydverunreinigungen
EA199700196A1 (ru) Способ получения фактора ix из биологических источников и фактор ix, полученный этим способом
DE69523038D1 (de) Verfahren zur herstellung von hiv proteasinhibitoren
ATE207880T1 (de) Verfahren zur herstellung von kontrastmitteln
NO308596B1 (no) FremgangsmÕte for fremstilling av faste, frittflytende vannløselige salter av aryloksy-C1-C4-alkankarboksylsyrer
US4894444A (en) Recovery and purification of immunogens from immunogen-alum complexes
ATE202146T1 (de) Verbesserte enzymatische kupplungsreaktion von n- geschützte l-asparaginsäure und phenylalaninmethylester
NZ516372A (en) Method for stabilising proteins in complex mixtures during their storage in aqueous solvents
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
AU642661B2 (en) A process for the purification of plasminogen activator inhibitor 2 (PAI-2)
Spadari et al. The terminal residues of aspergillopeptidase B
WO2003060118A1 (fr) Proteine fer-soufre, complexe proteine-fad, transporteur d'electrons, et procede de mesure de l'inhibition de l'activite de ferredoxine
JPH0532694A (ja) ポリペプチドの精製および活性化法
RU99107632A (ru) Способ получения лекарственного средства, содержащего протеин плазмы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application